FBW7 interacts with and degrades the oncogenic YTHDF2, consequently leading to stabilization of m6A-modified mRNAs, including the pro-apoptotic gene BMF, and impairment of ovarian cancer cell survival and proliferation. Here, FBXW7 is linked to ovarian carcinoma.